ArticlePDF Available

Atlas of the Global Burden of Stroke (1990–2013): the GBD 2013 Study

Authors:

Abstract and Figures

Background: World mapping is an important tool to visualize stroke burden and its trends in various regions and countries. Objectives: To show geographic patterns of incidence, prevalence, mortality, disability-adjusted life years (DALYs) and years lived with disability (YLDs) and their trends for ischemic stroke and hemorrhagic stroke in the world for 1990-2013. Methodology: Stroke incidence, prevalence, mortality, DALYs and YLDs were estimated following the general approach of the Global Burden of Disease (GBD) 2010 with several important improvements in methods. Data were updated for mortality (through April 2014) and stroke incidence, prevalence, case fatality and severity through 2013. Death was estimated using an ensemble modeling approach. A new software package, DisMod-MR 2.0, was used as part of a custom modeling process to estimate YLDs. All rates were age-standardized to new GBD estimates of global population. All estimates have been computed with 95% uncertainty intervals. Results: Age-standardized incidence, mortality, prevalence and DALYs/YLDs declined over the period from 1990 to 2013. However, the absolute number of people affected by stroke has substantially increased across all countries in the world over the same time period, suggesting that the global stroke burden continues to increase. There were significant geographical (country and regional) differences in stroke burden in the world, with the majority of the burden borne by low- and middle-income countries. Conclusions: Global burden of stroke has continued to increase in spite of dramatic declines in age-standardized incidence, prevalence, mortality rates and disability. Population growth and aging have played an important role in the observed increase in stroke burden.
Content may be subject to copyright.
E-Mail karger@karger.com
Atlas
Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
Atlas of the Global Burden of Stroke
(1990–2013): The GBD 2013 Study
ValeryL.Feigin a GeorgeA.Mensah d BoNorrving b ChristopherJ.L.Murray c
GregoryA.Roth c GBD 2013 Stroke Panel Experts Group
a FAAN, National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland ,
New Zealand;
b Department of Clinical Sciences, Neurology, Lund University, Lund , Sweden;
c Institute for Health
Metrics and Evaluation and the Division of Cardiology, School of Medicine, University of Washington, Seattle, Wash. ,
d Center for Translation Research and Implementation Science and Division of Cardiovascular Sciences; National
Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, Md. , USA
timates of global population. All estimates have been com-
puted with 95% uncertainty intervals. Results: Age-stan-
dardized incidence, mortality, prevalence and DALYs/YLDs
declined over the period from 1990 to 2013. However, the
absolute number of people affected by stroke has substan-
tially increased across all countries in the world over the
same time period, suggesting that the global stroke burden
continues to increase. There were significant geographical
(country and regional) differences in stroke burden in the
world, with the majority of the burden borne by low- and
middle-income countries. Conclusions: Global burden of
stroke has continued to increase in spite of dramatic declines
in age-standardized incidence, prevalence, mortality rates
and disability. Population growth and aging have played an
important role in the observed increase in stroke burden.
© 2015 S. Karger AG, Basel
Key Words
Stroke · Atlas · Burden · GBD 2013
Abstract
Background: World mapping is an important tool to visual-
ize stroke burden and its trends in various regions and coun-
tries. Objectives: To show geographic patterns of incidence,
prevalence, mortality, disability-adjusted life years (DALYs)
and years lived with disability (YLDs) and their trends for
ischemic stroke and hemorrhagic stroke in the world for
1990–2013. Methodology: Stroke incidence, prevalence,
mortality, DALYs and YLDs were estimated following the
general approach of the Global Burden of Disease (GBD)
2010 with several important improvements in methods.
Data were updated for mortality (through April 2014) and
stroke incidence, prevalence, case fatality and severity
through 2013. Death was estimated using an ensemble
modeling approach. A new software package, DisMod-MR
2.0, was used as part of a custom modeling process to esti-
mate YLDs. All rates were age-standardized to new GBD es-
Received: July 30, 2015
Accepted: September 15, 2015
Published online: October 28, 2015
Professor Valery L. Feigin, MD, MSc, PhD, FAAN
NISAN, AUT University, AUT North Shore Campus, AA254
90 Akoranga Dr, Northcote 0627
Auckland 1142 (New Zealand)
E-Mail valery.feigin @ aut.ac.nz
© 2015 S. Karger AG, Basel
0251–5350/15/0453–0230$39.50/0
www.karger.com/ned
Members of the GBD 2013 Stroke Panel Experts Group are listed in
the Appendix at the end of the paper.
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
Atlas of the Global Burden of Stroke Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
231
0–170
170–339
339–508
508–677
677–846
846–1,015
1,015–1,184
Fig. 1. Age-standardized annual prevalence (per 100,000) of ischemic stroke in 2013.
0–39
39–78
78–116
116–155
155–193
193–232
232–270
Fig. 2. Age-standardized annual prevalence (per 100,000) of hemorrhagic stroke in 2013.
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
Feigin etal.
Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
232
0–25
25–50
50–75
75–100
100–124
124–149
149–174
Fig. 3. Age-standardized annual mortality rates (per 100,000) of ischemic stroke in 2013.
0–32
32–64
64–95
95–127
127–159
159–190
190–222
Fig. 4. Age-standardized annual mortality rates (per 100,000) of hemorrhagic stroke in 2013.
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
Atlas of the Global Burden of Stroke Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
233
0–358
358–715
715–1,072
1,072–1,429
1,429–1,787
1,787–2,144
2,144–2,501
Fig. 5. Age-standardized annual DALYs rates (per 100,000) due to ischemic stroke in 2013.
0–638
638–1,276
1,276–1,914
1,914–2,552
2,552–3,190
3,190–3,828
3,828–4,465
Fig. 6. Age-standardized annual DALYs rates (per 100,000) due to hemorrhagic stroke in 2013.
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
Feigin etal.
Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
234
–30 to –19%
–19 to –8%
–8 to 3%
3 to 14%
14 to 25%
25 to 36%
36 to 47%
–27 to –13%
–13 to 2%
2 to 16%
16 to 31%
31 to 46%
46 to 60%
60 to 75%
Fig. 7. Percent change in age-standardized prevalence due to ischemic stroke for 1990–2013.
Fig. 8. Percent change in age-standardized prevalence due to hemorrhagic stroke for 1990–2013.
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
Atlas of the Global Burden of Stroke Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
235
–75 to –54%
–54 to –33%
–33 to –13%
–13 to 8%
8 to 29%
29 to 49%
49 to 70%
–76 to –43%
–43 to –10%
–10 to 24%
24 to 57%
57 to 90%
90 to 124%
124 to 157%
Fig. 9. Percent change in age-standardized mortality rates due to ischemic stroke for 1990–2013.
Fig. 10. Percent change in age-standardized mortality rates due to hemorrhagic stroke for 1990–2013.
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
Feigin etal.
Neuroepidemiology 2015;45:230–236
DOI: 10.1159/000441106
236
Acknowledgments
This work was undertaken as a part of the Global Burden of
Diseases, Injuries, and Risk Factors (GBD 2013) study. We thank
Sarah Safranek, University of Washington Health Sciences Li-
brary, for her help in developing the systematic review literature
search strategies; Michael F. MacIntyre, Brittany Wurtz and Sum-
mer Ohno, University of Washington Institute for Health Metrics
and Evaluation, for research coordination; Ryan M. Barber, Uni-
versity of Washington Institute for Health Metrics and Evaluation,
for creating figures and tables for the paper; Hannah Gardener,
University of Miami, for helping reviewing some studies; and Hel-
en McDonald, AUT University National Institute for Stroke And
Applied Neurosciences, for organizing teleconferences and secre-
tarial support. The authors alone are responsible for the views ex-
pressed in this publication.
Role of the Funding Source
This study was funded by the Bill and Melinda Gates Founda-
tion. The sponsor of the study had no role in the study design, data
collection, data analysis, data interpretation or writing of the re-
port. The GBD 2013 Core investigators had access to all data sourc-
es and were responsible for the content of the report and the deci-
sion to submit for publication.
Disclaimer
The views expressed in this article are those of the authors and
do not necessarily represent the views of the National Heart, Lung,
and Blood Institute; National Institutes of Health, or the US De-
partment of Health and Human Services.
Disclosure Statement
The authors have no conflict of interest to declare.
Appendix
GBD 2013 Stroke Panel Experts Group (in Alphabetical Order
by Country)
Argentina (Maria Cecilia Bahit); Australia (Amanda G. Thrift,
Atte Meretoja, Bill Stavreski, Craig S. Anderson, Edwin Pearse,
Geoffrey Donnan, Graeme J. Hankey, Mark T. Mackay, Stephen
Davis, Zanfina Ademi);
Austria (Michael Brainin); Azerbaijan
(Tural Guliyev); Bahrain (Randah R. Hamadeh); Barbados (Heath-
er Harewood, Karen Springer);
Brazil (Iuri da Costa Leite, Jefferson
Gomes Fernandes, Norberto Luiz Cabral, Paulo A. Lotufo);
Bulgaria (Klara Dokova); Canada (Farshad Pourmalek, Gabrielle
DeVeber, Luciano A. Sposato, M. Patrice Lindsay, Patricia M. Ric-
cio);
Chile (Pablo M. Lavados); China (Bin Li, Chuanhua Yu, Guo-
hong Jiang, Jixiang Ma, Maigeng Zhou, Ming Liu, Shankuan Zhu,
Wenzhi Wang, Xiaofeng Liang, Yong Zhang);
Colombia (Gabriel
Alcalá-Cerra);
Denmark (Hanne K. Christensen, Thomas Tru-
elsen);
Egypt (Foad Abd-Allah); Ethiopia (Awoke Temesgen, Ber-
he Weldearegawi Sahle, Semaw Ferede Abera, Yohannes Adama
Melaku);
Fiji (Devina Nand); France (Maurice Giroud); Germany
(Jost B. Jonas, Matthias Endres, Ronny Westerman);
Greece (Kon-
stantinos Stroumpoulis); India (Dorairaj Prabhakaran, Jeyaraj Du-
rai Pandian, Man Mohan Mehndiratta, Nobhojit Roy, Panniyam-
makal Jeemon, Rajeev Gupta, Vasanthan Rajagopalan);
Indonesia
(Soewarta Kosen, Tati Suryati Warouw);
Iran (Reza Malekzadeh);
Ireland (Martin J. O’Donnell); Israel (Natan M. Bornstein, David
Tanne);
Italy (Stefano Ricci, Valeria Caso); Japan (Yoshihiro
Kokubo, Yukito Shinohara);
Jordan (Majed Masoud Asad); Kenya
(Vitalis Kizito Bwire);
Korea (Sun Ha Jee, Young-Ho Khang);
Mexico (Ismael Campos-Nonato); Malaysia (Kim Yunjin, Ramesh
Sahathevan);
Morocco (Fortuné Gankpé); Myanmar (Chaw Yin
Myint); Netherlands (Johanna M. Geleijnse); New Zealand (Priya
Parmar, Rita V. Krishnamurthi, Suzanne Barker-Collo, Valery L.
Feigin);
Nigeria (Rufus Olusola Akinyemi); Norway (Ole Norhe-
im);
Qatar (Shams Eldin Khalifa); Russia (Michael Kravchenko,
Michael Piradov, Nikolay Shalamov, Vasiliy Victorovich Vlassov,
Yuri Varakin);
Rwanda (Jean De Dieu Ngirabega, Jean Pierre Ny-
emazi, Marie Aimee Muhimpundu);
Saudi Arabia (Mohammad
Saeedi, Neeraj Bedi);
Singapore (Narayanaswamy Venketasubra-
manian);
South Africa (Andre Pascal Kengne); Spain (David
Rojas-Rueda, Ferrán Catalá-López);
Sri Lanka (Samath D. Dhar-
maratne);
Sweden (Bo Norrving, Rasmus Havmoeller); Uganda
(Leo Atwine);
United Kingdom (Amitava Banerjee, Charles Wolfe,
Derrick A. Bennett, Finbar O’Callaghan, Ivy Shiue, Julia A. Critch-
ley, Majid Ezzati, Michael Soljak, Myles D. Connor, Peter M. Roth-
well, Rajiv Chowdhury, Rustam Al-Shahi Salman, William White-
ley, Zhengming Chen);
Uruguay (Mercedes Colomar); USA (Ad-
nan M. Durrani, Anand Dayama, Andrew E. Moran, Awoke
Misganaw, Brett M. Kissela, Catherine Amlie-Lefond, Catherine O.
Johnson, Cheng Huang, Christopher J.L. Murray, Chugh Sumeet,
Daniel Kim, David K. Cundiff, David Lawrence Tirschwell, Dhruv
S. Kazi, Dima Qato, Edmond Kato Kabagambe, Eric Ding, Gene
Bukhman, Gene Kwan, George A. Mensah, George D. Thurston,
Grant Nguyen, Gregory A. Roth, Josef Coresh, Kate Lefondulq,
Kevin N. Sheth, Matthew A. Corriere, Mohammad H. Forouzanfar,
Mohsen Naghavi, Nana Mainoo, Norman J. Beauchamp, Ralph L.
Sacco, Richard F. Gillum, Sanjay Basu, Stephen M. Schwartz, Su-
meet Chugh, Teresa Fung, Theo Vos, Tim E. Byers, Uchechukwu
K.A. Sampson, Walter A. Rocca, Warren Lo).
Downloaded by:
198.143.48.33 - 10/30/2015 4:20:48 AM
... Globally, stroke is the second most common cause of mortality and the third leading cause of disability with increased incidence in developing countries. 1 In India, among all deaths and disabilities, strokes contributing 7.3% and 3.5% of deaths and disability respectively. 2 The stroke resulted from interrupted blood flow to the brain or by a rupture of blood vessels in the brain. ...
... Worldwide, stroke is prevalent, and the recurrence rate of stroke within 5 years has reached as high as 40%. The regions with the heaviest burden of stroke disability are Asia, developing countries and the stroke belt of the United States (Feigin et al., 2015). Although the incidence of stroke has decreased globally, China, as a developing country, is facing an increasingly serious problem. ...
Article
Full-text available
Background Illness perceptions are an important factor affecting the prognosis of stroke patients. Evaluating the illness perceptions of stroke patients is of great importance for predicting their health behaviour and rehabilitation outcomes. However, there is no specific tool for assessing illness perceptions in stroke patients in China. Objectives The objective of this study is to translate the Stroke Illness Perception Questionnaire‐Revised (SIPQ‐R) into Chinese and to psychometrically test the Chinese version of the scale in the population of Chinese stroke patients. Methods This was a methodological study. We investigated 593 stroke patients in the neurology department of a hospital in China from March to September 2021. We translated the SIPQ‐R and adapted it to the cultural context, after which we evaluated the reliability and validity of the Chinese version of SIPQ‐R. Results Exploratory factor analysis identified eight common factors that accounted for 71.74% of the total variance, and the factor loadings ranged from 0.530 to 0.933. Confirmatory factor analysis confirmed the eight‐factor structure (χ²/df = 1.765, root mean square error of approximation = 0.053, incremental fit index = 0.906, comparative fit index = 0.905 and Tucker–Lewis index = 0.900). Internal consistency was confirmed by a Cronbach's alpha coefficient of 0.982. The test–retest reliability was 0.762. The results showed good content validity (the scale level content validity index was 0.940, and the item level content validity index values ranged from 0.860 to 0.960). There were no missing responses and floor or ceiling effects. The standard error of measurement and the smallest detectable change for the SIPQ‐R were 45.49 and 126.10, respectively. Conclusions The results of this study provide empirical evidence for the reliability and validity of the Chinese version of the SIPQ‐R for stroke patients.
Article
Full-text available
Background Stroke is a neurological condition characterized by high rates of disability and mortality. Magnetic resonance imaging (MRI) is widely used to examine the mechanisms of acupuncture in stroke treatment. Purpose This review provides neuroimaging evidence for the efficacy of acupuncture in treating stroke using MRI. Method We conducted a comprehensive search of databases, including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan Fang Data, Chinese BioMedical Literature Database (CBM), and Chonqing VIP (CQVIP), from inception to April 2024. Relevant neuroimaging studies on acupuncture for stroke were included, and the research findings were presented through charts and textual analyses. Results A total of 158 studies were included, and the overall methodological quality of the included studies was moderate to high. The results were divided into three categories: basic characteristics, clinical characteristics, and quality assessment of the included literature. Conclusion We elucidated the neural mechanisms underlying the effects of acupuncture on stroke; however, the evidence remains preliminary. There is a need for large-scale, well-designed, multimodal neuroimaging trials. This review represents the first active use of an evidence map to systematically review and illustrate the current state of neuroimaging research on the acupuncture treatment of stroke, thereby providing a valuable reference for future research.
Article
Purpose: Patients and families identify discharge from hospital as highly challenging. Less is known about experiences of transition between acute services and inpatient rehabilitation. We aimed to understand the experiences of patients and families as they transition to inpatient rehabilitation services, before and after the opening of a new integrated stroke and rehabilitation unit (ISU). Materials and methods: Adults were recruited 7 days after transfer to inpatient rehabilitation, in two 6-month periods before and after the opening of the ISU. Their experiences of care continuity were evaluated with a survey. Univariate analyses compared survey data pre- and post-ISU. A subset of participants completed semi-structured interviews that underwent thematic analysis. Results: 150 patients were recruited (median age 60 years, range 20-92 years, 72 female). There were no differences between pre- and post-ISU survey scores for patient or family experiences (all p > 0.3). Interview analysis identified 3 major themes: "Whānaungatanga - the foundation of patient experience", "In the dark and out of control", and "A nice view…but I want to be able to do more." Conclusions: Implementation of an integrated stroke and rehabilitation unit maintained levels of patient and family satisfaction. Interviews identified important themes for services planning to improve patient experience.
Article
Introduction: The absence of coronary artery calcium (CAC = 0) is associated with low risk of stroke events; however, predictors of incident stroke among those with CAC = 0 are not known. Methods: Individual participant-level data were pooled from three prospective cohorts (Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart Study). Multivariable-adjusted Cox proportional hazards models were used to study the association between cardiovascular risk factors and incident adjudicated stroke among individuals with CAC = 0 who were free of clinical atherosclerotic cardiovascular disease at baseline. Results: Among 6180 participants (mean age 53 [SD 11] years, 62% women, and 44% White, 36% Black, and 20% other individuals), over a median (IQR) follow up of 15 (12-16) years, there were 122 strokes (95 ischemic, 27 hemorrhagic) with an overall unadjusted event rate of 2.0 per 1000 person-years. After multivariable adjustment, risk factors associated with overall stroke included (hazard ratio [95% CI]) systolic blood pressure (SBP): 1.19 (1.05-1.36) per 10-mmHg increase and carotid intima-media thickness (CIMT): 1.21 (1.04-1.42) per 0.1-mm increment. Current cigarette smoking: 2.68 (1.11-6.50), SBP: 1.23 (1.06-1.42) per 10-mmHg increase, and CIMT: 1.25 (1.04-1.49) per 0.1-mm increment were associated with ischemic stroke, whereas C-reactive protein was associated with hemorrhagic stroke risk (0.49, 0.25-0.93). Conclusion: In a large cohort of individuals with CAC = 0, the rate for incident stroke was low (2.0 per 1000-person years) and was associated with modifiable risk factors.
Article
Tại Việt Nam, đột quỵ là nguyên nhân hàng đầu gây tử vong, tàn tật. Nghiên cứu cắt ngang trên 166 người bệnh đột quỵ não điều trị tại Bệnh viện Chuyên khoa Ngoại Thần kinh Quốc tế nhằm đánh giá chất lượng cuộc sống của họ theo thang đo SS-QOL tại hai thời điểm sau khi điều trị ổn định, sau 3 tháng và một số yếu tố liên quan. Kết quả điểm trung bình chất lượng cuộc sống người bệnh đột quỵ não sau khi điều trị ổn định: 166.84 ± 42.83. Cụ thể: Sức khỏe thể chất: 51.75 ± 11.02; Sức khỏe chức năng: 64.8 ± 23.49; Yếu tố tâm lý: 28.86 ± 7.69; Yếu tố gia đình-xã hội: 21.44 ± 8.84. Điểm trung bình chất lượng cuộc sống sau 3 tháng: 178.08 ± 43.78. Cụ thể: Sức khỏe thể chất: 54.47 ± 10.06; Sức khỏe chức năng: 71.39 ± 21.88; Yếu tố tâm lý: 28.92 ± 8.58; Yếu tố gia đình-xã hội: 23.3 ± 9.9. Các yếu tố liên quan gồm: Sử dụng bảo hiểm y tế, nghề nghiệp, tình trạng hôn nhân, chức năng sinh hoạt hằng ngày, vị trí liệt, yếu tố nguy cơ (bệnh tim, rối loạn lipid máu, rượu bia, thuốc lá) (p < 0.05). Bệnh viện Chuyên khoa Ngoại Thần kinh Quốc tế cần xây dựng những mô hình hỗ trợ chăm sóc toàn diện cho người bệnh, hướng dẫn gia đình họ những vấn đề tâm lý, phục hồi chức năng để góp phần nâng cao chất lượng cuộc sống của người bệnh sau đột quỵ.
Article
Full-text available
Objectives Epidemiological studies of stroke and its risk factors can help develop strategies to prevent stroke. We aimed to explore the current gender-specific prevalence of stroke and associated risk factors. Methods Data were collected using a structured precoded questionnaire designed by the Stroke Screening and Prevention Programme of the National Health and Wellness Commission Stroke Prevention and Control Project Committee, between June 2020 and November 2021. A total of 7394 residents took part in the study, 187 of whom had a stroke. The baseline information of each participant was obtained and included in this study. The chi-square test and Kruskal-Wallis tests were used to examine the relationship between these indicators and stroke, and then multivariate logistic regression was used to construct the prediction scale between different genders. Results of 7394 participants,4571 (61.82%) were female. The overall prevalence of stroke patients in the study population was 2.53%, Multivariate analysis found that residence status (OR = 0.43, p = 0.002) 、HCY (OR = 0.962, p = 0.000)、Previous TIA (OR = 0.200, p = 0.002) 、Hypertension (OR = 0.33, p = 0.000) and Dyslipidemia (OR = 0.668, p = 0.028) were significant predictors of stroke. there are gender differences in the traditional risk factors for stroke, and women have more risk factors. ROC analysis confirmed the accuracy of the stroke risk model, and the AUC of the stroke risk model for the general population was 0.79 with p < 0.05. In the gender model, the female AUC was 0.796 (p < 0.05). and the male AUC was 0.786 with p < 0.05. Conclusion The prevalence of stroke in adults aged 40 years and above is high in eastern China were high. management of risk factors can effectively prevent the occurrence of most strokes. more attention should be paid to gender differences associated with stroke.
Marie Aimee Muhimpundu) Saudi Arabia (Mohammad Saeedi, Neeraj Bedi); Singapore (Narayanaswamy Venketasubramanian ); South Africa (Andre Pascal Kengne); Spain (David Rojas-Rueda, Ferrán Catalá-López); Sri Lanka (Samath D. Dharmaratne ); Sweden
  • Mexicoamitava Banerjee
  • Charles Wolfe
  • Derrick A Bennett
  • O Finbar
  • Ivy Callaghan
  • Julia A Shiue
  • Majid Critchley
  • Michael Ezzati
  • Myles D Soljak
  • Peter M Connor
  • Rajiv Rothwell
  • Chowdhury
Mexico (Ismael Campos-Nonato); Malaysia (Kim Yunjin, Ramesh Sahathevan); Morocco (Fortuné Gankpé); Myanmar (Chaw Yin Myint); Netherlands (Johanna M. Geleijnse); New Zealand (Priya Parmar, Rita V. Krishnamurthi, Suzanne Barker-Collo, Valery L. Feigin); Nigeria (Rufus Olusola Akinyemi); Norway (Ole Norheim ); Qatar (Shams Eldin Khalifa); Russia (Michael Kravchenko, Michael Piradov, Nikolay Shalamov, Vasiliy Victorovich Vlassov, Yuri Varakin); Rwanda (Jean De Dieu Ngirabega, Jean Pierre Nyemazi, Marie Aimee Muhimpundu); Saudi Arabia (Mohammad Saeedi, Neeraj Bedi); Singapore (Narayanaswamy Venketasubramanian ); South Africa (Andre Pascal Kengne); Spain (David Rojas-Rueda, Ferrán Catalá-López); Sri Lanka (Samath D. Dharmaratne ); Sweden (Bo Norrving, Rasmus Havmoeller); Uganda (Leo Atwine); United Kingdom (Amitava Banerjee, Charles Wolfe, Derrick A. Bennett, Finbar O'Callaghan, Ivy Shiue, Julia A. Critchley, Majid Ezzati, Michael Soljak, Myles D. Connor, Peter M. Rothwell, Rajiv Chowdhury, Rustam Al-Shahi Salman, William Whiteley, Zhengming Chen); Uruguay (Mercedes Colomar); USA (Adnan M. Durrani, Anand Dayama, Andrew E. Moran, Awoke Misganaw, Brett M. Kissela, Catherine Amlie-Lefond, Catherine O. Johnson, Cheng Huang, Christopher J.L. Murray, Chugh Sumeet, Daniel Kim, David K. Cundiff, David Lawrence Tirschwell, Dhruv S. Kazi, Dima Qato, Edmond Kato Kabagambe, Eric Ding, Gene Bukhman, Gene Kwan, George A. Mensah, George D. Thurston, Grant Nguyen, Gregory A. Roth, Josef Coresh, Kate Lefondulq, Kevin N. Sheth, Matthew A. Corriere, Mohammad H. Forouzanfar, Mohsen Naghavi, Nana Mainoo, Norman J. Beauchamp, Ralph L.
Awoke Temesgen, Berhe Weldearegawi Sahle, Semaw Ferede Abera
  • Ethiopia
Ethiopia (Awoke Temesgen, Berhe Weldearegawi Sahle, Semaw Ferede Abera, Yohannes Adama Melaku);